THE EFFECTS OF GLUCOCORTICOIDS ON PHORBOL ESTER AND CYTOKINE-STIMULATED TRANSCRIPTION FACTOR ACTIVATION IN HUMAN LUNG

被引:67
作者
ADCOCK, IM [1 ]
SHIRASAKI, H [1 ]
GELDER, CM [1 ]
PETERS, MJ [1 ]
BROWN, CR [1 ]
BARNES, PJ [1 ]
机构
[1] NATL HEART & LUNG INST, DEPT THORAC MED, LONDON SW3 6LY, ENGLAND
基金
英国医学研究理事会;
关键词
LUNG; GLUCOCORTICOID RECEPTORS; ACTIVATION PROTEIN-1; NF-KAPPA-B; CROSS COUPLING;
D O I
10.1016/0024-3205(94)00243-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glucocorticoids have a wide variety of effects which result in the dampening of inflammatory and immune responses and other challenges to homeostasis. An important site of steroid action may be on the control of transcription factor binding to DNA. The interaction of the transcription factors, activator protein 1 (AP-1) and nuclear factor kappa from B cells (NF kappa B) with DNA and glucocorticoid receptors was analysed by gel mobility shift assays following stimulation by tumour necrosis factor alpha (TNF alpha) and a phorbol ester (PMA) that activates protein kinase C. PMA and TNF alpha both caused significant (180-340%) increases in AP-1 and NF kappa B DNA binding which peaked at 15 minutes and decreased to a constant elevated level at between 1-3 hrs and was sustained for 24 hrs. Dexamethasone (1 mu M) caused a rapid and long lasting 40-50% decrease in both AP-1 and NF kappa B DNA binding lasting over 24 hrs. Combined treatment with dexamethasone and PMA or TNF alpha prevented the increase in both AP-1 and NF kappa B binding due to PMA and TNF alpha returning levels to those seen in control untreated samples. This suggests that in human lung, the glucocorticoid receptor functionally interacts within the nucleus with other transcription factors that are induced by inflammatory mediators such as cytokines. This may be an important molecular site of steroid action in chronic inflammatory lung diseases such as asthma.
引用
收藏
页码:1147 / 1153
页数:7
相关论文
共 21 条
[1]  
ADCOCK I M, 1992, American Review of Respiratory Disease, V145, pA834
[2]   COUPLED AND UNCOUPLED INDUCTION OF FOS AND JUN TRANSCRIPTION BY DIFFERENT 2ND MESSENGERS IN CELLS OF HEMATOPOIETIC ORIGIN [J].
AUWERX, J ;
STAELS, B ;
SASSONECORSI, P .
NUCLEIC ACIDS RESEARCH, 1990, 18 (02) :221-228
[3]  
BARNES PJ, 1989, NEW ENGL J MED, V321, P1517
[4]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[5]   THE MOLECULAR ACTION OF TUMOR-NECROSIS-FACTOR-ALPHA [J].
CAMUSSI, G ;
ALBANO, E ;
TETTA, C ;
BUSSOLINO, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 202 (01) :3-14
[6]   TRANSCRIPTION FACTOR INTERACTIONS - SELECTORS OF POSITIVE OR NEGATIVE REGULATION FROM A SINGLE DNA ELEMENT [J].
DIAMOND, MI ;
MINER, JN ;
YOSHINAGA, SK ;
YAMAMOTO, KR .
SCIENCE, 1990, 249 (4974) :1266-1272
[7]  
JACKSON ME, 1991, J CELL SCI, V100, P1
[8]   ANTITUMOR PROMOTION AND ANTIINFLAMMATION - DOWN-MODULATION OF AP-1 (FOS JUN) ACTIVITY BY GLUCOCORTICOID HORMONE [J].
JONAT, C ;
RAHMSDORF, HJ ;
PARK, KK ;
CATO, ACB ;
GEBEL, S ;
PONTA, H ;
HERRLICH, P .
CELL, 1990, 62 (06) :1189-1204
[9]   CYTOKINES OF THE LUNG [J].
KELLEY, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03) :765-788
[10]   FOS IS A PREFERENTIAL TARGET OF GLUCOCORTICOID RECEPTOR INHIBITION OF AP-1 ACTIVITY INVITRO [J].
KERPPOLA, TK ;
LUK, D ;
CURRAN, T .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) :3782-3791